The Nebraska Cancer Research Center
Since 1984, The Nebraska Cancer Research Center has been a leader in cancer research, providing local access to National Cancer Institute-sponsored cancer clinical trials. Over 1,900 volunteers have participated in treatment, prevention and control trials through NCRC, helping to identify more effective cancer treatments and improve the quality of life of cancer patients.
- Posted by Jeri on 06/04/2014
- Posted by Jeri on 05/21/2014
- Posted by Jeri on 02/21/2014
WHAT IS A CLINICAL TRIAL?
New Clinical TrialsView all clinical trials available at NCRC.
S1300: Non-Squamous Cell Lung Cancer - A Randomized, Phase II Trial of Crizotinib Plus Pemetrexed Versus Pemetrexed Monotherapy in ALK-Positive Non-Squamous NSCLC Patients Who Have Progressed Systematically After Previous Clinical Benefit From Crizotinib Monotherapy.
S1406: Metastatic Colorectal Cancer - A Randomized Phase II Study of Irinotecan and Cetuximab with or without Vemurafenib in BRAF Mutant Metastatic Colorectal Cancer.
RU2214081: Pilot Clinical Trial Evaluating the Utility of Minocycline as an Agent to Decrease Chemotherapy-Induced Neuropathy and Paclitaxel-induced Acute Pain Syndrome
Alliance A081105: Non-small Cell Lung Cancer - Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)